There were 374 press releases posted in the last 24 hours and 441,336 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Editas Medicine Announces In Vivo Proof-of-Concept Data for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image